| View |
|
DRP-8465-02
|
Amoxicillin (as trihydrate)
|
Trixen-250
|
250 mg/ 5 mL
|
Powder for Suspension
|
Anibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
11 September 2023
|
27 September 2027
|
| View |
|
DRP-8466-01
|
Amoxicillin (as trihydrate)
|
Trixen-125
|
125 mg/ 5 mL
|
Powder for Suspension
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
CLIDP Conversion
|
28 September 2023
|
27 September 2027
|
| View |
|
DRP-8477-02
|
Hyoscine N-Butylbromide
|
Spalax
|
10 mg
|
Film-Coated Tablet
|
Anticholinergic
|
Sapphire Lifesciences Pvt. Ltd.
|
India
|
CLIDP Conversion
|
26 September 2023
|
16 May 2027
|
| View |
|
DRP-8624-03
|
Ibuprofen
|
Sqfen
|
200mg/5mL
|
Suspension (Orange Flavor)
|
Antipyretic/Analgesic/Non-Steroidal Anti-Inflammatory Drug
|
LifeSquare Laboratories, Inc
|
Philippines
|
CLIDP Conversion
|
10 October 2023
|
15 January 2025
|
| View |
|
DRP-8627-05
|
Paracetamol
|
Optipar
|
10 mg/mL (1 g/100 mL)
|
Solution for Injection for I.V. Infusion
|
Analgesic/Antipyretic
|
Furen Pharmaceutical Group Co., Ltd
|
China
|
CLIDP Conversion
|
03 September 2023
|
15 January 2025
|
| View |
|
DRP-869-01
|
Ranitidine (as Hydrochloride)
|
Eastidine
|
25 mg/mL
|
Solution for Injection (IM/IV)
|
H2 Receptor Antagonist
|
Cadila Pharmaceuticals Ltd.
|
India
|
Renewal
|
05 October 2023
|
12 March 2029
|
| View |
|
DRP-8745-04
|
Cefuroxime (as sodium)
|
Cefatex
|
750 mg
|
Powder for Injection (I.M./I.V.)
|
Antibacterial (Cephalosporin)
|
Theon Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
02 October 2023
|
20 February 2025
|
| View |
|
DRP-885-09
|
Salbutamol (as Sulfate)
|
Salbustan
|
2 mg/5 mL
|
Syrup
|
Selective Beta-2-Adrenoreceptor Agonist
|
J.M. Tolmann Laboratories Inc
|
Philippines
|
CLIDP Conversion
|
26 September 2023
|
29 November 2025
|
| View |
|
DRP-8962-02
|
Doxorubicin Hydrochloride
|
DoxoHealth 10
|
10 mg
|
Lyophilized Powder for IV Injection/Infusion
|
Antineoplastic (Anthracycline and related substances)
|
Admac Lifesciences
|
India
|
CLIDP Conversion
|
11 October 2023
|
08 August 2028
|
| View |
|
DRP-8977-02
|
Pramipexole dihydrochloride monohydrate
|
None
|
1 mg
|
Tablet
|
Anti-Parkinson Drug (Dopamine Agonist)
|
Sun Pharmaceutical Industries Ltd.
|
India
|
CLIDP Conversion
|
11 October 2023
|
08 April 2028
|
| View |
|
DRP-8985-06
|
Losartan Potassium
|
Lifetan
|
50mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
11 October 2023
|
21 July 2025
|
| View |
|
DRP-9038-01
|
Clonazepam
|
Vermazepine
|
2 mg
|
Tablet
|
Antiepileptic (Benzodiazepine derivative)
|
Remedica Ltd.
|
Cyprus
|
CLIDP Conversion
|
13 October 2023
|
05 November 2026
|
| View |
|
DRP-9124-07
|
Lactulose
|
Cleargut
|
3.33g / 5 mL
|
Oral Solution
|
Laxative
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
11 September 2023
|
04 September 2025
|
| View |
|
DRP-9166-06
|
Clopidogrel
|
Clopicard
|
75mg
|
Film-Coated Tablet
|
Antithrombotic Agent
|
Zim Laboratories Limited
|
India
|
CLIDP Conversion
|
13 September 2023
|
21 September 2025
|
| View |
|
DRP-9178-02
|
Paracetamol + Guaifenesin + Phenylpropanolamine HCl + Dextromethorphan HBr + Chlorphenamine maleate
|
Maxituss
|
325 mg/50 mg/30 mg/15 mg/1 mg
|
Capsule
|
Analgesic/Expectorant/Nasal Decongestant/Antitussive/Antihistamine
|
Azarias Pharmaceutical Laboratories Inc.
|
Philippines
|
CLIDP Conversion
|
13 October 2023
|
28 September 2025
|
| View |
|
DRP-9183-01
|
Lactulose
|
Rifelac
|
3.33 g/5 mL
|
Syrup
|
Laxative
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
15 September 2023
|
30 September 2025
|
| View |
|
DRP-9549-01
|
Ibuprofen
|
None
|
200 mg
|
Tablet
|
Analgesic / Antipyretic / Non-Steroidal Anti-Inflammatory Drug (NSAID)
|
Scheele Laboratories Phils., Inc
|
Philippines
|
CLIDP Conversion
|
25 September 2023
|
18 February 2026
|
| View |
|
DRP-9668-01
|
Ceftriaxone (as sodium)
|
Q Taxone
|
1 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
CLIDP Conversion
|
11 October 2023
|
27 April 2026
|
| View |
|
DRP-9921-02
|
Sevoflurane
|
Sevomed
|
100% Volatile Liquid for Inhalation
|
|
General Anesthetic
|
Lunan Better Pharmaceutical Co., Ltd
|
China
|
CLIDP Conversion
|
11 September 2023
|
16 January 2025
|
| View |
|
DRP-9966-02
|
Amoxicillin (as Trihydrate)
|
Amoxden
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
|
China
|
Renewal
|
18 February 2024
|
08 February 2029
|